Grant Awards in October 2003

Preface >>
Facts and Figures >>

Principal Investigator Project Title/Link
Dr. Thomas J. Dengler
Medizinische Universitätsklinik, Heidelberg, Germany
Immunological Properties and Therapeutic Potential of Endothelial Precursor Cells in Transplantation
Dr. Geoffrey Hill
The Queensland Institute of Medical Research, Herston, Australia
New Approaches to Prevent Transplant Rejection
Dr. Sheri M. Krams
Stanford University, Stanford, USA
NK Cells in Transplantation
Dr. Fadi G. Lakkis
Yale University School of Medicine, New Haven, USA
Long-Term Acceptance of Transplanted Organs
Dr. Alain Le Moine
Université Libre de Bruxelles, Brussels, Belgium
Suppression of Allograft Rejection and Tolerance Induction by Self-Regulatory T Cells
Dr. Andrew D. Luster
Massachusetts General Hospital, Charlestown, USA
The Role of White Blood Cell Attractans in the Development of Rejection and Organ Failure after Lung Transplantation
Dr. Anette Melk
University of Heidelberg, Heidelberg, Germany
Cell Cycle Regulator p16 as a Mechanism for Long-Term Graft Failure
Prof. Jacques-P. Tremblay
CHUL Research Center, Sainte-Foy, Canada
Development of Central Immunological Tolerance towards Myoblasts Transplantation
Dr. Jiangping Wu
Notre-Dame Hospital, University of Montreal, Montreal, Canada
Use of a Death Decoy Protein to Protect Organ Graft from Rejection
Dr. Yong-Guang Yang
Massachusetts General Hospital, Boston, USA
Approach to Preventing Xenograft Rejection
Dr. Nicholas Zavazava
University of Iowa Health Care, Iowa City, USA
Application of Embryonic Stem Cells to Avoid Rejection of Transplanted Organs